TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

Charlotte Levin Tykjær Jørgensen, Christina Bjerre, Bent Ejlertsen, Karsten D. Bjerre, Eva Balslev, Annette Bartels, Nils Brünner, Dorte Lisbet Nielsen

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number360
JournalBMC Cancer
Volume14
DOIs
Publication statusPublished - 2014
Externally publishedYes

Cite this